期刊文献+

宫颈癌治疗后主动脉旁淋巴转移调强放疗剂量学研究及临床观察 被引量:4

Dosimetric comparison and clinical observation of intensity modulated radiation therapy for cervical cancer patients with para-aortic lymph node metastasis
原文传递
导出
摘要 目的:探讨调强放射治疗(intensity modulated radiotherapy,IMRT)应用于宫颈癌治疗后主动脉旁淋巴结转移的剂量学特点、治疗效果及在减少并发症方面的价值。方法:选取2005—06—01—2012—12—30临沂市肿瘤医院(65例)和山东省肿瘤医院(51例)接受全程IMRT或适形放疗(conventional radiotherapy,CRT)治疗的116例主动脉旁淋巴结转移的宫颈癌患者。56例宫颈癌治疗后主动脉旁淋巴结转移患者接受全程IMRT,给予PTV剂量(58~69)Gy/(29~30)次,2.0~2.3Gy/次,中位剂量63.5Gy,随机选择10例患者,用三维治疗计划系统进行IMRT和常规放疗(CRT)计划设计,拟给予相同的处方剂量,比较危及器官受照射剂量。随机选择同期接受CRT(60例)患者,比较IMRT和CRT的靶区剂量、疗效、急性和晚期毒副作用及生存率。结果:56例患者均完成全程IMRT,95%的等剂量曲线可以覆盖99%的PTV体积,IMRT与拟行CRT计划比较,IMRT计划中小肠(t=2.958,P=0.016)、肾脏(t=14.438,P〈0.001)和脊髓(t=34.511,P〈0.001)受照射剂量明显降低,靶区剂量明显提高,t=20.924,P〈0.001,IMRT组的急性和慢性毒副作用均明显减少,P〈0.05。两组完全缓解率(x2=11.048,P=0.001)、部分缓解率(x2=5.893,P=0.015)和总有效率(x2=32.251,P〈0.001)比较差异均有统计学意义;1、3和5年生存率比较差异有统计学意义,x2=9.530,P=0.002。结论:IMRT对宫颈癌治疗后主动脉旁淋巴结转移患者可获得理想的剂量分布,邻近危及器官得到保护,临床疗效满意,毒副作用明显减少,有效率提高,生存期明显延长。 OBJECTIVE: To investigate the dosimetry and clinical outcomes of intensity modulated radiotherapy (IMRT) versus conventional radiotherapy (CRT) for patients of cervical cancer with para-aortic lymph node metastasis after radiotherapy. METHODS: This retrospective study used dates from 116 patients completed full course of IMRT or CRT in Shandong Linyi Tumor Hospital(65 cases)and Shandong Cancer Hospital(51cases)from June 1,2005 to December 30,2012. All 56 patients completed full course of IMRT, 2.0 to 2.3 Gy/fraction to the PTV. The total dose was 58~ 69 Gy and the median dose was 63.5 Gy. Simultaneously conventional para-aortic lymph node radiation plan was designed for 10 patients with the same prescription dose. The dose of organs at risk were compared. Sixty cases received CRT with para-aortic lymph node metastasis after radiotherapy were chosen to compare the target dose, efficacy, acute and chronic toxicity as well as survival rate with the 56 IMRT cases. RESULTS: In the IMRT group, 95% of iso-dose curve covered more than 99% PTV. IMRT plans compared with CRT plans, the dose of small intestine(t= 2. 958, P= 0. 016), kidney (t = 14. 438, P〈0. 001), spinal(t= 34.511, P〈 0. 001 ) were significantly lower. Compared with CRT, target dose of IM- RT was significantly increased(t= 20. 924, P〈0. 001). The acute and chronic toxicity of IMRT was significantly decreased (P〈0. 05). The complete remission rate(X2 = 11. 048, P= 0. 001), partial remission rate (X2 = 5. 893, P = 0. 015) and o- verall response rate(X2= 32.251, P〈0.001) were significantly increased. The survival rates of 1,3,5-year had significant difference(x2 = 9. 530,P=0. 002). CONCLUSIONS.. IMRT therapy makes better dose distribution than CRT for cervical cancer patients with para-aortic lymph node metastasis after radiotherapy, target area can obtain radical dose. The adjacent organs at risk can be protected well. IMRT has satisfying efficacy and tolerable toxicities. Overall response rate and surviv- al rate are significantly higher.
出处 《中华肿瘤防治杂志》 CAS 北大核心 2014年第16期1274-1278,共5页 Chinese Journal of Cancer Prevention and Treatment
关键词 子宫颈癌 淋巴结转移 主动脉旁 调强放射治疗 常规放疗 预后 Cervical Cancer,Lymphatic metastasis,Para-aortic lymph node, Intensity Modulated Radiotherapy, Con-ventional radiotherapy,Prognosis
  • 相关文献

参考文献18

  • 1Fletcher GH,Rutiledge FN. Extended field technique in the man- agement of the carcinoma of the uterine cervix[J]. Am I Roent Rad Therapy Nucle Med, 1972,114(1) : 116-122.
  • 2陈真云,盛修贵,秦中平,李秀敏.子宫颈癌术后淋巴结转移同步加量调强放射治疗的临床观察[J].中华肿瘤防治杂志,2013,20(3):226-230. 被引量:13
  • 3Yun Liang, Karen Messer, Brent S, et al. The impact of bone mattow radiation dose on acute hematologic toxicity in cervical cancer:principal component analysis on high dimensional date [J]. Int J Radiat Oncol Biol Phys,2010,78(3) :912-919.
  • 4Gandhi AK,Sharma DN,Rath GK, et al. Early clinical outcomes and toxicity of intensity modulated versus conventional pelvic ra- diation therapy for locally advanced cervix carcinoma: a prospec- tive randomized study[J]. Int J Radiat Onco Bio| Phys, 2013,87 (3) :542-548.
  • 5Renard-Oldrini S, Brunaud C, H uger S, et al. Dosimetric compari- son between the intensity modulated radiotherapy with fixed field and Rapid Arc of cervix cancer[J]. Cancer Radiotherapy, 2012,16(3) :209-214.
  • 6Roszak A, Wareficzak-Florczak Z, Bratos K, et al. Incidence of ra- diation toxicity in cervical cancer and endometrial cancer patients treated with radiotherapy alone versus adjuvant radiotherapy [J]. Rep Pract Oncol Radiother2012,17(6) : 332-338.
  • 7Kaplan EL, Meier P. Nonparametric estimation from incomplete observations[J]. J Am Stat Assoc[J'] 1958,53 : 457-481.
  • 8Wang S, Ai P, Xie L, et al. Dosimetric comparison of different multileaf collimator leaves in treatment planning of intensity-modulated radiotherapy for cervical cancer [J]. Med Dosim, 2013,38(4) : 454-459.
  • 9Khosla D, Patel FD, Rai B, et al. Dose escalation by intensity- modulated radiotherapy boost after whole pelvic radiotherapy in postoperative patients of carcinoma cervix with residual disease [J]. Clin Oneol (R Coll Radiol) ,2013,25(1) : 1-6.
  • 10Liu SP, Huang X,Ke GH, et al. 3D Radiation Therapy or Inten- sity-Modulated Radiotherapy for Recurrent and Metastatic Cer- vical Cancer:The Shanghai Cancer Hospital Experience[J]. PLoS 0ne,2012,7(6) :e40299.

二级参考文献36

  • 1陈真云,盛修贵,马悦冰,薛莉,张小玲,宋趣清.宫颈癌常规放疗后盆腔复发的调强放疗研究[J].中华放射肿瘤学杂志,2007,16(3):186-187. 被引量:12
  • 2FLETCHER G H,RUTILEDGE F N.Extended field technique in the management of the cancer of the uterine cervix[J].Rad Therapy Nucle Med,1972,114(1):116-122.
  • 3Intensity Modulated Radiation Therapy Collaborative Working Group.Intensity-modulated radiotherapy:Current status and issues of interest[J].Int J Radiat Oncol Biol Phys,2001,51(4):880-914.
  • 4INOUE T,MORITA K.Long-term observation of patients treated by postoperative extended field irradiation for nodal mestastases from cervical carcinima stages Ⅰ B,Ⅱ A,and Ⅱ B[J].Gynecol Oncol,1995,58(1):4-10.
  • 5PALEY P J,GOFF B A,MINUDRI R,et al.The prognostic signiticance of radiation dose and residual tumor in the treatment of barrel-shaped endophytic cervical carcinoma[J].Gynecol Oncol,2000,76(3):373-379.
  • 6van de BUNT L,van der HEIDE U A,KETELAARS M,et al.Conventional,conformal,and intensity-modulated radiation therapy treatment planning of external beam radiotherapy for cervical cancer:The impact of tumor regression[J].Int J Radiat Oncol Biol Phys,2006,64(1):189-196.
  • 7GERSZTEN K,COLONELLO K,HERON D E,et al.Feasibility of concurrent cisplatin and extended field radiation therapy(EFRT) using intensity-modulated radiotherapy(IMRT) for carcinoma of the cervix[J].Gyneocl Oncol,2006,102 (2):182-188.
  • 8AHMED R S,KIM R Y,DUAN J,et al.IMRT dose escalation for positive para-aortic lymph nodes in patients with locally advanced cervical cancer while reducing dose to bone marrow and other organs at risk[J].Int J Radiat Oncol Biol Phys,2004,60(2):505-512.
  • 9MUTIC S,MALYPA R S,GRIGSBY P W,et al.PET-guided IMRT for cervical carcinima with positive para-aortic lymphnodes-adose-escalation treatment planning study[J].Int J radiat oncol Biol Phys,2003,55 (1):28-35.
  • 10谢聪颖,吴式琇,金献测,余建义,王建华,李文峰,张萍.同步加速调强放射治疗鼻咽癌的临床研究[J].中华医学杂志,2007,87(34):2412-2415. 被引量:2

共引文献38

同被引文献15

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部